John J. McCabe
Keine laufenden Positionen mehr
Profil
John J.
McCabe worked as a Senior Associate at Coopers & Lybrand LLP.
He then worked as a Controller at Interleukin Genetics, Inc. for nine years.
McCabe was also a Controller at Satcon Technology Corp.
He served as Vice President-Finance at Clinical Data, Inc. from 2010 to 2011.
McCabe was the Chief Financial Officer at Sesen Bio, Inc. from 2016 to 2017.
He then worked as the Senior VP, Chief Financial & Accounting Officer at resTORbio, Inc. from 2017 to 2020.
McCabe received his undergraduate degree from the University of Vermont.
Ehemalige bekannte Positionen von John J. McCabe
| Unternehmen | Position | Ende |
|---|---|---|
| ADICET BIO, INC. | Finanzdirektor/CFO | 31.07.2020 |
| CARISMA THERAPEUTICS, INC. | Finanzdirektor/CFO | 20.10.2017 |
Clinical Data, Inc.
 Clinical Data, Inc. Medical SpecialtiesHealth Technology Clinical Data, Inc. manufactured and distributed scientific instruments used in clinical and analytical laboratories. The company was founded in 1972 and was headquartered in Newton, MA. | Finanzdirektor/CFO | 01.06.2011 |
| Coopers & Lybrand LLP | Corporate Officer/Principal | - |
| SATCON TECHNOLOGY CORPORATION | Comptroller/Controller/Auditor | - |
Ausbildung von John J. McCabe
| University of Vermont | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Interleukin Genetics, Inc. engages in the marketing and development of proprietary genetic tests for chronic inflammatory diseases and health-related conditions focuses on metabolism and inflammation. The company was founded in 1986 and is headquartered in Waltham, MA. | Health Technology |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Clinical Data, Inc.
Clinical Data, Inc. Medical SpecialtiesHealth Technology Clinical Data, Inc. manufactured and distributed scientific instruments used in clinical and analytical laboratories. The company was founded in 1972 and was headquartered in Newton, MA. | Health Technology |
Satcon Technology Corp.
 Satcon Technology Corp. SemiconductorsElectronic Technology Satcon Technology Corp. operates as a energy and power company. It provides system design services for utility-scale renewable energy plants. The firm designs and delivers advanced power conversion solutions that enable producers of renewable energy to convert clean energy into grid-connected and reliable electrical power. The company was founded by David B. Eisenhaure in February 1985 and is headquartered in Boston, MA. | Electronic Technology |
| Coopers & Lybrand LLP | Commercial Services |
resTORbio, Inc.
 resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA. | Health Technology |
